September 30, 2020
Thomas Frinzi is the former Worldwide President, Surgical, Johnson & Johnson Vision business, which includes a broad ophthalmology portfolio across the areas of cataracts and refractive surgery (LASIK). Tom was appointed to his position in February 2017 at the conclusion of Johnson & Johnson’s acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott Laboratories and President, Abbott Medical Optics.
Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.
October 1, 2020
As President and CEO of CorneaGen, Bernie is responsible for all aspects of the tissue services organization. Over his career, he has been responsible for the distribution of more than 150,000 sight restoring grafts to nearly 50 countries worldwide.
Bernie began his career in eye banking in 1995, when he joined SightLife as an eye bank technician. In 2003, he became the Chief Operating Officer overseeing all operations, including clinical services and quality assurance. He transitioned to CorneaGen COO after its creation in 2016. In early 2021, Bernie was promoted to President of the organization.
For 15 years he served on the Medical Advisory Board for the Eye Bank Association of America (EBAA), which creates and revises the medical standards that govern eye banking, and was an Inspector on the Accreditation Board for 15 years, which determines EBAA accreditation status of eye banks. In 2016, Bernie was honored by the EBAA with the Leonard Heise Award for his outstanding devotion to the field of eye banking.
Bernie has been a member of the American Association of Ophthalmology and American Society of Cataract and Refractive Surgery course faculty for Femtosecond Laser Keratoplasty.
Bernie received his master’s degree in Health Administration from the University of Washington and graduated cum laude with a Bachelor of Science in Zoology, also at the UW.
April 12, 2022
Patrick Lally is a partner at Petrichor Healthcare Capital Management, a life sciences-focused investment firm. Prior to joining Petrichor, Mr. Lally was a vice president at OrbiMed Advisors in their healthcare special situations and structured finance practice. Before OrbiMed, Mr. Lally was a healthcare investor in the Drawbridge Special Opportunities Fund at Fortress Investment Group. Mr. Lally holds an M.B.A. from The Wharton School at the University of Pennsylvania and an A.B. in Molecular Biology from Princeton University.
October 1, 2020
Dr. Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology and visiting professor at the UC Irvine Gavin Herbert Eye Institute.
Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.
After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972. He has been awarded over 40 patents in ophthalmology and has developed a number of corneal preservation solutions, intraocular lenses and instruments that are used in clinical practices globally. He has co-edited seven books, published over 350 peer reviewed journals and 60 book chapters.
He is the recipient of numerous awards for distinguished service by national and international ophthalmology associations, including the LANS, Barraquer and the first lifetime achievement award from the International Society of Refractive Surgery.
December 9, 2022
Jane E. Rady serves as senior vice president, corporate strategy and business development at Glaukos. From 2017 to April 2018, she was vice president, business development for Johnson & Johnson Surgical Vision, following the 2017 acquisition by Johnson & Johnson of Abbott Medical Optics, a division of Abbott Laboratories. From 2009 to 2017, she was divisional vice president, business development for Abbott Medical Optics. From 2002 to 2009, she held several executive leadership positions at Advanced Medical Optics, Inc. (AMO), which was acquired by Abbott Laboratories in 2009. While at AMO, Ms. Rady headed various functions, including business development, strategic planning, research and development, clinical development, regulatory affairs and government affairs. Her prior experiences includes positions at Monsanto Corporation, G.D. Searle and Abbott Laboratories. Ms. Rady holds a B.S. in biology and a M.S. in molecular biology/microbiology from the University of Illinois and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.